Source: Annual Congress 2001 - Asthma treatment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Meguro, P. W. Jones (London, United Kingdom). Use of asthma rescue medication in response to nonsymptom triggers. Eur Respir J 2001; 16: Suppl. 31, 413

Member's Comments

No comment yet.

Related content which might interest you: Effect of Dupilumab on patient-reported breathing and rescue medication use Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020 Asthma patients adjust their maintenance treatment late in response to worsening asthma symptoms Source: Eur Respir J 2005; 26: Suppl. 49, 7s Year: 2005 High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs Source: Eur Respir J 2012; 40: 1072-1074 Year: 2012 Does adherence to ICS/LABA therapy affect response to mepolizumab in the treatment of severe asthma? Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Physician‘s perception of pediatric asthma control is influenced by the use of medication Source: Eur Respir J 2003; 22: Suppl. 45, 365s Year: 2003 Are a degree of asthma therapy related to asthma control impairment? Source: Eur Respir J 2003; 22: Suppl. 45, 370s Year: 2003 Omalizumab improves asthma control in patients receiving high-dose ICS and multiple other controller therapies and who have continuing impairment of lung function and asthma symptoms Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 Asthma control and medication use five years after early or delayed introduction of inhaled corticosteroids in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 34s Year: 2003 Rescue/acute and allergy medication use among children on asthma controller therapy Source: Eur Respir J 2004; 24: Suppl. 48, 378s Year: 2004 Real-life asthma impairment: SABA use depends on smoking phenotype Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Which are the factors and causes that lead to omalizumab withdrawal in severe asthma patients? Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Combination asthma medication and healthcare use in severe or difficult-to-treat asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004 Self-care behavior for medications use and treatment outcome in elderly with asthma Source: Annual Congress 2010 - Dysfunctional breathing, asthma and respiratory physiotherapy problems Year: 2010 Is omalizumab response influenced by passive smoking in severe asthma? Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Attitudes to inhaler devices are associated with self-reported adherence to asthma therapy Source: Eur Respir J 2006; 28: Suppl. 50, 840s Year: 2006 Suboptimal asthma control in patients receiving long-term maintenance therapy Source: Annual Congress 2006 - The challenges of managing asthma in primary care Year: 2006 Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Understanding patient’ adherence to inhaled medication: the social representations of COPD Source: International Congress 2017 – COPD management Year: 2017 Episodic high reliever use with budesonide/formoterol maintenance and reliever therapy confers added protection against asthma exacerbations Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma Year: 2007